FDA announces pilot program to curb illegal opioid sales

The FDA is launching a 120-day pilot program aimed at reducing online transactions involving unapproved opioids, according to a June 8 news release.

Advertisement

Three internet registries will participate in the program: Neustar, Verisign and Public Interest Registry. The FDA will notify the registries when it sends a warning letter to a website operator and the operator does not respond sufficiently or within the allotted time frame. The internet registries will assess the next course of action in each case, which may lead to blocking or domain suspension.

The National Telecommunications and Information Administration is partnering with the FDA on this project, and the two agencies will jointly assess its effectiveness.

More articles on pharmacy:
Drug wholesale, net prices increasing at slower rate, study says
U of Utah terminates faculty appointment of researcher involved in retracted Lancet study
Florida pharmacy owners charged in $54M kickback scheme

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.